Möchten Sie immer auf dem neuesten Stand bleiben?

Company announcement – No. 03 / 2019 Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress Copenhagen, March 7, 2019 – Zealand Pharma A/S (“Zealand”)...

Press release – No. 04 / 2019 Zealand Pharma to attend Credit Suisse and BioCapital Healthcare Conferences Copenhagen, March 1, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend...

Company announcement – No. 02 / 2019 Zealand Pharma announces registration of executive management and an update of the Articles of Association Copenhagen, February 28, 2019 – Zealand Pharma A/S...

Press Release – No. 03 / 2019   Zealand hosts conference call on March 7 at 4 pm CET (10 am EST) to present fourth quarter and full year results for 2018 Copenhagen, February 25, 2019 – Zealand...

Company announcement – No. 1/2019 Changes to Zealand Pharma’s Executive Management                Copenhagen, Denmark, January 23, 2019 – Zealand Pharma A/S today announced changes to its Executive...

Press release – No. 2 / 2019 Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum Copenhagen, January 4, 2019 – Britt Meelby Jensen, President and Chief Executive Officer of...

Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta...

Company announcement – No. 32 / 2018 Total number of shares and voting rights in Zealand Pharma at December 31, 2018 Copenhagen, December 28, 2018 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...

Company announcement – No. 31 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, December 14, 2018 – Zealand Pharma A/S (“Zealand”)...

Company announcement – No. 30/2018 Financial calendar for Zealand Pharma in 2019 Copenhagen, December 10, 2018 – Zealand Pharma A/S (“ZEAL”) announces the following dates for the company's...